Cystatin C is a strong predictor of survival in patients with cirrhosis: Is a cystatin C-based MELD better?

Liver International

Volumn 32, Issue 8, 2012, Pages 1211-1216

  Finkenstedt, Armin ^a   Dorn, Livia ^a   Edlinger, Michael ^a   Prokop, Wolfgang ^b   Risch, Lorenz ^a   Griesmacher, Andrea ^b   Graziadei, Ivo ^a   Vogel, Wolfgang ^a   Zoller, Heinz ^a  

^a INNSBRUCK MEDICAL UNIVERSITY   (Austria)

^b UNIVERSITY HOSPITAL INNSBRUCK   (Austria)

Author keywords

Liver transplantation; Mortality; Prognostic model; Renal function

Indexed keywords

CREATININE; CYSTATIN C;

ADULT; ARTICLE; CALCULATION; CALIBRATION; CONTROLLED STUDY; END STAGE LIVER DISEASE; FATALITY; FEMALE; FOLLOW UP; HAZARD RATIO; HUMAN; LIVER CIRRHOSIS; LIVER TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; MORTALITY; PROGNOSIS; PROPORTIONAL HAZARDS MODEL; SEX DIFFERENCE; SURVIVAL PREDICTION;

ADULT; AGED; BIOLOGICAL MARKERS; CREATININE; CYSTATIN C; END STAGE LIVER DISEASE; FEMALE; HUMANS; LIVER CIRRHOSIS; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; RETROSPECTIVE STUDIES; RISK FACTORS; ROC CURVE; SEX DISTRIBUTION;

EID: 84865170131     PISSN: 14783223     EISSN: 14783231     Source Type: Journal    
DOI: 10.1111/j.1478-3231.2012.02766.x     Document Type: Article

References (16)

1. Malinchoc M, Kamath PS, Gordon FD, et al. A model to predict poor survival in patients undergoing transjugular intrahepatic portosystemic shunts. Hepatology 2000; 31: 864-71.
2. Kamath PS, Wiesner RH, Malinchoc M, et al. A model to predict survival in patients with end-stage liver disease. Hepatology 2001; 33: 464-70.
3. Benckert C, Quante M, Thelen A, et al. Impact of the MELD allocation after its implementation in liver transplantation. Scand J Gastroenterol 2011; 46: 941-8.
4. Bambha KM, Biggins SW. Inequities of the model for end-stage liver disease: an examination of current components and future additions. Curr Opin Organ Transplant 2008; 13: 227-33.
5. Ripoll C, Banares R, Rincon D, et al. Influence of hepatic venous pressure gradient on the prediction of survival of patients with cirrhosis in the MELD Era. Hepatology 2005; 42: 793-801.
6. Ruf AE, Kremers WK, Chavez LL, et al. Addition of serum sodium into the MELD score predicts waiting list mortality better than MELD alone. Liver Transpl 2005; 11: 336-43.
7. Luca A, Angermayr B, Bertolini G, et al. An integrated MELD model including serum sodium and age improves the prediction of early mortality in patients with cirrhosis. Liver Transpl 2007; 13: 1174-80.
8. Kim WR, Biggins SW, Kremers WK, et al. Hyponatremia and mortality among patients on the liver-transplant waiting list. N Engl J Med 2008; 359: 1018-26.
9. Gerbes AL, Gulberg V, Bilzer M, et al. Evaluation of serum cystatin C concentration as a marker of renal function in patients with cirrhosis of the liver. Gut 2002; 50: 106-10.
10. Gonwa TA, Jennings L, Mai ML, et al. Estimation of glomerular filtration rates before and after orthotopic liver transplantation: evaluation of current equations. Liver Transpl 2004; 10: 301-9.
11. Myers RP, Shaheen AA, Aspinall AI, et al. Gender, renal function, and outcomes on the liver transplant waiting list: assessment of revised MELD including estimated glomerular filtration rate. J Hepatol 2011; 54: 462-70.
12. Orlando R, Mussap M, Plebani M, et al. Diagnostic value of plasma cystatin C as a glomerular filtration marker in decompensated liver cirrhosis. Clin Chem 2002; 48(6 Pt 1): 850-8.
13. Newman DJ, Thakkar H, Edwards RG, et al. Serum cystatin C measured by automated immunoassay: a more sensitive marker of changes in GFR than serum creatinine. Kidney Int 1995; 47: 312-8.
14. Randers E, Kristensen JH, Erlandsen EJ, et al. Serum cystatin C as a marker of the renal function. Scand J Clin Lab Invest 1998; 58: 585-92.
15. Seo YS, Jung ES, An H, et al. Serum cystatin C level is a good prognostic marker in patients with cirrhotic ascites and normal serum creatinine levels. Liver Int 2009; 29: 1521-7.
16. Moylan CA, Brady CW, Johnson JL, et al. Disparities in liver transplantation before and after introduction of the MELD score. JAMA 2008; 300: 2371-8.